Artificial heart to give new hope to heart failure patients
A revolutionary, implantable mechanical device to be tested at The Alfred is set to provide new hope to patients with debilitating heart failure.
Visitor information – Everything you need to know about visiting our sites.
For more than 50 years, The Alfred Cardiothoracic Surgery Clinical Trials Unit has been improving the clinical outcomes of patients with heart disease, lung disease and traumatic chest injuries.
We need clinical trials to prove that a new medication, device or treatment is safe and effective for people.
Without clinical trials, new treatments and medicines cannot be approved for use in Australia.
The Alfred Cardiothoracic Surgery Clinical Trials Unit improves treatments for patients with heart disease, lung disease and traumatic chest injuries.
We assess scientific literature and previous research to:
We also compare new surgical methods against our standard practices to continually improve our patient’s clinical outcomes.
Find out more about our Cardiothoracic Surgery service.
There are four different phases of a clinical trial. Each phase is represented by a roman numeral.
We focus on conducting clinical trials which test:
We also conduct retrospective studies, where we look at historical clinical information of patients who have received a new surgical intervention including medical devices.
The Cardiothoracic Surgery Clinical Trials team are leaders in their fields, with decades of Australian and international experience:
ClinTrial Refer is a quick way to see all of our open trials, in one place. It’s the easy way to find a trial that may be right for you or your patient.
A revolutionary, implantable mechanical device to be tested at The Alfred is set to provide new hope to patients with debilitating heart failure.
Heart patients of the future are set to benefit from a new partnership which will bring together the combined strengths of three leading institutions in cardiovascular research and patient care.
When 43-year-old Melbourne dad Mark Wohlers suffered a cardiac arrest last year, it was the swift emergency response and an Australian-first clinical trial that gave him a second chance at life.